Visceral disseminated varicella zoster virus infection in a patient with rheumatoid arthritis treated with immunosuppressive therapy including a Janus kinase inhibitor

J Dermatol. 2023 Mar;50(3):e92-e93. doi: 10.1111/1346-8138.16580. Epub 2022 Sep 19.

Authors

Marika Matsuya¹, Shigetsuna Komatsu¹, Toshifumi Iida², Yoshio Hashimoto¹, Masaru Honma^{3

4}, Akemi Ishida-Yamamoto⁴

Affiliations

¹ Department of Dermatology, Asahikawa Kosei General Hospital, Asahikawa, Japan.
² Department of Gastroenterology, Asahikawa Kosei General Hospital, Asahikawa, Japan.
³ International Medical Support Center, Asahikawa Medical University, Asahikawa, Japan.
⁴ Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.

PMID: 36117465
DOI: 10.1111/1346-8138.16580

No abstract available

Publication types

Letter

MeSH terms

Arthritis, Rheumatoid* / drug therapy
Chickenpox*
Herpes Zoster* / diagnosis
Herpes Zoster* / drug therapy
Herpesvirus 3, Human
Humans
Immunosuppression Therapy
Janus Kinase Inhibitors*

Substances

Janus Kinase Inhibitors